Sexually Transmitted Disease Testing Market
Sexually Transmitted Disease (STD) Testing Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Disease (Chlamydia, Syphilis, Gonorrhea, Hyper Simplex Virus Human Immunodeficiency Virus, Chancroid); By Location (Laboratory, Point of Care (PoC)); By Device (Laboratory Devices, Point of Care (PoC) Devices); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
- Published Date: January 2023
- Report ID: BWC23024
- Available Format: PDF
- Page: 200
Report Overview
Increasing reimbursements for sexually transmitted diseases (STDs) testing across the countries, high prevalence and rise in incidences of STDs across the world, and implementation of national screening programs are projected to propel the expansion of Global Sexually Transmitted Diseases (STDs) Testing Market during the forecast period between 2023 and 2029.Global Sexually Transmitted Disease Testing Market - Industry Trends & Forecast Report, 2029
Global sexually transmitted disease (STD) testing market size was estimated at USD 91.4 billion in 2022. During the forecast period between 2023 and 2029, the size of global sexually transmitted disease (STD) testing market is projected to grow at a CAGR of 6.2% reaching a value of USD 135.5 billion by 2029. Major growth drivers for global sexually transmitted disease testing market include increasing public awareness and patient education, global rise in the incidence of sexually transmitted illnesses, increasing patient awareness through education campaigns, and a surge in government activities. The prevalence and incidence of sexually transmitted illnesses have increased significantly during the previous decade. As the frequency of sexually transmitted illnesses increases, countries worldwide are focused on the deployment of national screening programs to expand the coverage of STD diagnosis. Also, the payment regulations for services related to STDs have been favorable. Technology advancements and developments in the diagnosis of STDs are also projected to boost market expansion. Increased national screening program implementation to increase STD diagnosis coverage will also boost the demand for STDs testing. These reasons are considerably driving the growth of the global STDs testing market.
Global Sexually Transmitted Disease Testing Market– Overview
Sexual health testing is a collection of diverse tests and procedures used to diagnose and detect sexually transmitted illnesses such as Chlamydia, Gonorrhea, Trichomonas, HIV, HSV, HCV, HPV, and others. For sexual health testing, four major types of testing are employed, including Culture/Isolation of Organisms, Molecular Test, Immunology Assay, and others. HIV can be diagnosed using one of three HIV tests: antibody testing, antigen/antibody tests, and nucleic acid tests (NAT). STD prevalence and incidence have risen considerably in the recent decade. As the prevalence of sexually transmitted illnesses rises, nations around the world are focusing on developing nationwide screening programs to increase the adoption of STD diagnostics coverage. Furthermore, reimbursement regulations for diagnostic services for STDs have been useful. These factors are significantly contributing to the growth of the global STDs diagnostics market.
Global Sexually Transmitted Disease Testing Market
Growth Drivers
High Prevalence & Rise in Incidences of STDs across the Globe
Sexually transmitted infections have a significant global influence on sexual and reproductive health. In 2019, teenagers and young adults aged 15 to 24 years constituted for more than 55% of reported cases of sexually transmitted infections. In 2020, the World Health Organization (WHO) recorded 374 million cases of one of four STIs. The most instances were acquired by Chlamydia (129 million), preceded by gonorrhea, syphilis, and trichomoniasis. In 2018, HPV infections were connected to 570,000 cases of cervical cancer and over 311,000 deaths from the disease. According to the Cleveland Clinic, about 20 million new STD infections occur each year. An estimated 820,000 persons died from hepatitis B in 2019, the majority from hepatocellular cancer and cirrhosis. The frequency of all these infections among people is steadily increasing because of unprotected sex, a lack of understanding, and multiple partner intimacy. As a result, testing for STDs is becoming increasingly prevalent, boosting the market growth.
Restraints
Social Stigma Associated with Patients Visiting Specialized STD Clinics
Numerous STDs are socially stigmatized. In other words, people are judged or chastised for having STDs and other diseases. The STD stigma is usually exceedingly strong. HIV stigma refers to negative attitudes and ideas held towards HIV-positive people. It is the unfavorable views that result from classifying someone as a member of a socially unacceptable group. Because of a lack of information and awareness, as well as antiquated attitudes, people are terrified of obtaining HIV. Furthermore, many individuals assume that HIV is a sickness that affects just certain ethnicities. This leads to moral judgments towards HIV-positive people. HIV patients internalize the stigma they face and develop a bad self-image. If their HIV status is exposed, they may be terrified of being judged or discriminated against. Hence, such factors are anticipated to restrain the market growth.
Impact of COVID-19 on Global Sexually Transmitted Disease Testing Market
COVID-19 had a detrimental impact on the STD (sexually transmitted disease) testing market. Due to disruptions in healthcare and STD testing facilities, the CDC (Centers for Disease Control and Prevention) observed a decline in STD testing during the early months of COVID-19. Few members may have unwittingly disseminated the virus due to inadequate testing and diagnosis. As a result, even though the transmission of STDs rose during the pandemic, the market value declined due to the decrease in testing. STD testing surged once the lockdown and travel ban were lifted, and the market is projected to boost the expansion of market growth.
Global Sexually Transmitted Disease Testing Market
Segmental Coverage
Global Sexually Transmitted Disease Testing Market – By Disease
By disease, global sexually transmitted disease testing market is divided into Chlamydia, Syphilis, Gonorrhoea, Hyper Simplex Virus, Human Immunodeficiency Virus, and Chancroid segments. The Chlamydia segment accounted for the highest market share in 2022. However, the HPV infection segment is expected to skyrocket during the forecast period. The Centers for Disease Control and Prevention (CDC) received 616,392 complaints of gonorrhea in 2019, making it the second most common reportable disease in the US.
Global Sexually Transmitted Disease Testing Market – By Location
Based on location, global sexually transmitted disease testing market is bifurcated in Laboratory and Point of Care (PoC). In 2022, the laboratory testing segment held a higher market share, but point-of-care testing is predicted to rise at the quickest rate in the years ahead. Laboratory testing includes commercial/private labs and public health labs. Laboratory testing is a time-consuming but more exact procedure that involves commercial/private labs as well as public health labs. Likewise, point-of-care testing segment includes testing kits, is faster, the results may be less exact. However, bedside testing or mobile testing that allows for rapid healthcare provision for patients is capturing market share. There has been a major transition from traditional laboratory tests to rapid and easy PoC tests, due to the benefits provided by point of care testing equipment.
Global Sexually Transmitted Disease Testing Market – By Device
Based on location, global sexually transmitted disease testing market is bifurcated laboratory Devices and Point of Care (PoC) Devices segments. The laboratory devices segment is subdivided into Thermal Cyclers PCR, Lateral Flow Readers- Immune Chromatographic Arrays, Flow Cytometers, Differential Light Scattering Machines, and Absorbance Micro Plate Reader-Enzyme-Linked Immunosorbent Assay (ELISA). During the forecast period, PCR for STD diagnosis is expected to hold the highest market share. Phone chips (microfluidics and ICT) and portable/bench top/rapid diagnostic kits are examples of point of care testing equipment. The point-of-care testing equipment technological advancements result in accurate and trustworthy results. In 2022, the market for portable POC testing devices dominated the market.
Global Sexually Transmitted Disease Testing Market – By Region
Geographically, global sexually transmitted disease testing market covers major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The Asia-Pacific region held the highest market share in 2022. A rise in the number of STI cases, a surge in the youth population, a lack of knowledge, and increased government activities are driving the Asia-Pacific STD testing market. North America, on the other hand, will see considerable growth in the next years because of the presence of important companies, the availability of technologically advanced products, and the increasing acceptance of point of care testing.
Competitive Landscape
Major players operating in global sexually transmitted disease testing market include Abbott Laboratories, BioMérieux, Inc., Becton Dickinson Company, Danaher Corporation, Bio-Rad Laboratories, Inc., Hologic, Inc., Diasorin Molecular LLC, Roche Holding AG, Orasure Technologies, Inc., Thermo Fisher Scientific Inc., AccuBioTech Co. Ltd., AdvaCare Pharma, BIOGENIX Inc. Pvt Ltd., CTK Biotech Inc., Everlywell Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, and Merck and Co. Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
Recent Developments
-
In May 2022 – Becton, Dickinson and Group launched a new, fully automated, high-throughput infectious disease molecular diagnostics platform, the BD COR MX instrument, in the US. The test is a single test that detects the three most common non-viral STIs: Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginitis (TV). These three STIs can result in a variety of negative patient outcomes, ranging from pregnancy difficulties to increased HIV risk.
Scope of the Report
Attributes |
Details |
Years Considered |
Historical Data – 2019–2022 |
Base Year – 2022 |
|
Estimated Year – 2023 |
|
Forecast Period – 2023–2029 |
|
Facts Covered |
Revenue in USD Million |
Market Coverage |
North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, The Netherlands, Belgium, NORDIC Countries, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Philippines, Vietnam, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Peru, Colombia, Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Qatar, Kuwait, Iran, South Africa, Nigeria, Kenya, Egypt, Morocco, Algeria, Rest of Middle East & Africa) |
Product/ Service Segmentation |
Disease, Location, Drive, Region |
Key Players |
Abbott Laboratories, BioMérieux, Inc., Becton Dickinson Company, Danaher Corporation, Bio-Rad Laboratories, Inc., Hologic, Inc., Diasorin Molecular LLC, Roche Holding AG, Orasure Technologies, Inc., Thermo Fisher Scientific Inc., AccuBioTech Co. Ltd., AdvaCare Pharma, BIOGENIX Inc. Pvt. Ltd., CTK Biotech Inc., Everlywell Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Merck and Co. Inc. |
By Disease
-
Chlamydia
-
Syphilis
-
Gonorrhoea
-
Hyper Simplex Virus
-
Human Immunodeficiency Virus
-
Chancroid
By Location
-
Laboratory
-
Point of Care (POC)
By Device
-
Laboratory Devices
-
Point of Care (PoC) Devices
By Region
-
North America
-
Europe
-
Asia Pacific (APAC)
-
Latin America
-
Middle East and Africa (MEA)
- Research Framework
- Research Objective
- Product Overview
- Market Segmentation
- Executive Summary
- Global Sexually Transmitted Disease Testing Market Insights
- Industry Value Chain Analysis
- DROC Analysis
- Growth Drivers
- High Prevalence & Rise in Incidences of STD across the Globe
- Implementation of National Screening Programs
- Supporting Reimbursement of STDs Testing
- Restraints
- Social Stigma Associated with Patients Visiting Specialized STD Clinics
- Huge Protection of Patients Infected with STDs in Remotes Areas
- Opportunities
- Decrease In Number of Visits to Government Clinics
- National Screening Programs Across the Globe
- Niche Opportunities for Technology and POC Test Providers in an Emerging Economy
- Challenges
- Stringent Regulations
- Growth Drivers
- Technology Advancements/Recent Developments
- Regulatory Framework
- Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
- Global Sexually Transmitted Disease Testing Market Overview
- Market Size & Forecast by Value, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Disease
- Chlamydia
- Syphilis
- Gonorrhoea
- Hyper Simplex Virus
- Human Immunodeficiency Virus
- Chancroid
- Others
- By Location
- Laboratory
- Commercial/Private Labs
- Public Health Labs
- Point of Care (POC)
- Laboratory
- By Device
- Laboratory Devices
- Thermal Cyclers PCR
- Lateral Flow Readers- Immune Chromatographic Arrays
- Flow Cytometers
- Differential Light Scattering Machines
- Absorbance Micro Plate Reader- Enzyme- Linked Immunosorbent Assay (ELISA)
- Others
- Point of Care (POC) Devices
- Laboratory Devices
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- By Disease
- Market Size & Forecast by Value, 2019–2029
- North America Sexually Transmitted Disease Testing Market
- Market Size & Forecast by Value, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Disease
- By Location
- By Device
- By Country
- US
- By Disease
- By Location
- By Device
- Canada
- By Disease
- By Location
- By Device
- US
- Market Size & Forecast by Value, 2019–2029
- Europe Sexually Transmitted Disease Testing Market
- Market Size & Forecast by Value, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Disease
- By Location
- By Device
- By Country
- Germany
- By Disease
- By Location
- By Device
- UK
- By Disease
- By Location
- By Device
- Italy
- By Disease
- By Location
- By Device
- France
- By Disease
- By Location
- By Device
- Spain
- By Disease
- By Location
- By Device
- The Netherlands
- By Disease
- By Location
- By Device
- Rest of Europe
- By Disease
- By Location
- By Device
- Germany
- Market Size & Forecast by Value, 2019–2029
- Asia-Pacific Sexually Transmitted Disease Testing Market
- Market Size & Forecast by Value, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Disease
- By Location
- By Device
- By Country
- China
- By Disease
- By Location
- By Device
- India
- By Disease
- By Location
- By Device
- Japan
- By Disease
- By Location
- By Device
- South Korea
- By Disease
- By Location
- By Device
- Australia & New Zealand
- By Disease
- By Location
- By Device
- Indonesia
- By Disease
- By Location
- By Device
- Malaysia
- By Disease
- By Location
- By Device
- Singapore
- By Disease
- By Location
- By Device
- Philippines
- By Disease
- By Location
- By Device
- Vietnam
- By Disease
- By Location
- By Device
- Rest of APAC
- By Disease
- By Location
- By Device
- China
- Market Size & Forecast by Value, 2019–2029
- Latin America Sexually Transmitted Disease Testing Market
- Market Size & Forecast by Value, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Disease
- By Location
- By Device
- By Country
- Brazil
- By Disease
- By Location
- By Device
- Mexico
- By Disease
- By Location
- By Device
- Argentina
- By Disease
- By Location
- By Device
- Peru
- By Disease
- By Location
- By Device
- Colombia
- By Disease
- By Location
- By Device
- Rest of LATAM
- By Disease
- By Location
- By Device
- Brazil
- Market Size & Forecast by Value, 2019–2029
- Middle East & Africa Sexually Transmitted Disease Testing Market
- Market Size & Forecast by Value, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Disease
- By Location
- By Device
- By Country
- Saudi Arabia
- By Disease
- By Location
- By Device
- UAE
- By Disease
- By Location
- By Device
- Qatar
- By Disease
- By Location
- By Device
- Kuwait
- By Disease
- By Location
- By Device
- South Africa
- By Disease
- By Location
- By Device
- Nigeria
- By Disease
- By Location
- By Device
- Algeria
- By Disease
- By Location
- By Device
- Rest of MEA
- By Disease
- By Location
- By Device
- Saudi Arabia
- Market Size & Forecast by Value, 2019–2029
- Competitive Landscape
- List of Key Players and Their Offerings
- Global Sexually Transmitted Disease Testing Company Market Share Analysis, 2022
- Competitive Benchmarking, By Operating Parameters
- Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)
- Impact of Covid-19 on Global Sexually Transmitted Disease Testing Market
- Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
- Abbott Laboratories
- BioMérieux, Inc.
- Becton Dickinson Company
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Hologic, Inc.
- Diasorin Molecular LLC
- Roche Holding AG
- Orasure Technologies, Inc.,
- Thermo Fisher Scientific Inc.
- AccuBioTech Co. Ltd.
- AdvaCare Pharma
- BIOGENIX Inc. Pvt. Ltd.
- CTK Biotech Inc.
- Everlywell Inc.
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- Merck and Co. Inc.
- Other Prominent Players
- Key Strategic Recommendations
- Research Methodology
- Qualitative Research
- Primary & Secondary Research
- Quantitative Research
- Market Breakdown & Data Triangulation
- Secondary Research
- Primary Research
- Breakdown of Primary Research Respondents, By Region
- Assumption & Limitation
- Qualitative Research
*Financial information in case of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable
List of Figures
Figure 1 Global Sexually Transmitted Disease Testing Market Segmentation
Figure 2 Global Sexually Transmitted Disease Testing Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2022
Figure 4 Global Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 5 Global Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 6 Global Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 7 Global Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 8 Global Sexually Transmitted Disease Testing Market Share, By Region, By Value, 2019–2029
Figure 9 North America Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 10 North America Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 11 North America Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 12 North America Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 13 North America Sexually Transmitted Disease Testing Market Share, By Country, By Value, 2019–2029
Figure 14 US Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 15 US Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 16 US Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 17 US Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 18 Canada Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 19 Canada Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 20 Canada Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 21 Canada Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 22 Europe Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 23 Europe Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 24 Europe Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 25 Europe Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 26 Europe Sexually Transmitted Disease Testing Market Share, By Country, By Value, 2019–2029
Figure 27 Germany Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 28 Germany Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 29 Germany Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 30 Germany Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 31 UK Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 32 UK Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 33 UK Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 34 UK Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 35 Italy Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 36 Italy Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 37 Italy Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 38 Italy Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 39 France Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 40 France Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 41 France Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 42 France Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 43 Spain Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 44 Spain Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 45 Spain Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 46 Spain Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 47 The Netherlands Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 48 The Netherlands Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 49 The Netherlands Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 50 The Netherlands Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 51 Rest of Europe Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 52 Rest of Europe Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 53 Rest of Europe Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 54 Rest of Europe Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 55 Asia-Pacific Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 56 Asia-Pacific Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 57 Asia-Pacific Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 58 Asia-Pacific Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 59 Asia-Pacific Sexually Transmitted Disease Testing Market Share, By Country, By Value, 2019–2029
Figure 60 China Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 61 China Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 62 China Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 63 China Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 64 India Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 65 India Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 66 India Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 67 India Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 68 Japan Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 69 Japan Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 70 Japan Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 71 Japan Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 72 South Korea Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 73 South Korea Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 74 South Korea Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 75 South Korea Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 76 Australia & New Zealand Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 77 Australia & New Zealand Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 78 Australia & New Zealand Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 79 Australia & New Zealand Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 80 Indonesia Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 81 Indonesia Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 82 Indonesia Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 83 Indonesia Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 84 Malaysia Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 85 Malaysia Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 86 Malaysia Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 87 Malaysia Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 88 Singapore Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 89 Singapore Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 90 Singapore Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 91 Singapore Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 92 Philippines Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 93 Philippines Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 94 Philippines Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 95 Philippines Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 96 Vietnam Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 97 Vietnam Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 98 Vietnam Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 99 Vietnam Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 100 Rest of APAC Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 101 Rest of APAC Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 102 Rest of APAC Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 103 Rest of APAC Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 104 Latin America Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 105 Latin America Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 106 Latin America Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 107 Latin America Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 108 Latin America Sexually Transmitted Disease Testing Market Share, By Country, By Value, 2019–2029
Figure 109 Brazil Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 110 Brazil Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 111 Brazil Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 112 Brazil Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 113 Mexico Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 114 Mexico Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 115 Mexico Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 116 Mexico Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 117 Argentina Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 118 Argentina Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 119 Argentina Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 120 Argentina Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 121 Peru Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 122 Peru Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 123 Peru Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 124 Peru Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 125 Colombia Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 126 Colombia Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 127 Colombia Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 128 Colombia Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 129 Rest of LATAM Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 130 Rest of LATAM Sexually Transmitted Disease Testing Market Share, By Disease. By Value, 2019–2029
Figure 131 Rest of LATAM Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 132 Rest of LATAM Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 133 Middle East & Africa Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 134 Middle East & Africa Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 135 Middle East & Africa Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 136 Middle East & Africa Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 137 Middle East & Africa Sexually Transmitted Disease Testing Market Share, By Country, By Value, 2019–2029
Figure 138 Saudi Arabia Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 139 Saudi Arabia Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 140 Saudi Arabia Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 141 Saudi Arabia Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 142 UAE Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 143 UAE Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 144 UAE Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 145 UAE Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 146 Qatar Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 147 Qatar Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 148 Qatar Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 149 Qatar Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 150 Kuwait Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 151 Kuwait Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 152 Kuwait Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 153 Kuwait Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 154 South Africa Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 155 South Africa Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 156 South Africa Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 157 South Africa Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 158 Nigeria Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 159 Nigeria Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 160 Nigeria Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 161 Nigeria Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 162 Algeria Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 163 Algeria Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 164 Algeria Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 165 Algeria Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
Figure 166 Rest of MEA Sexually Transmitted Disease Testing Market Size, By Value (USD Billion), 2019–2029
Figure 167 Rest of MEA Sexually Transmitted Disease Testing Market Share, By Disease, By Value, 2019–2029
Figure 168 Rest of MEA Sexually Transmitted Disease Testing Market Share, By Location, By Value, 2019–2029
Figure 169 Rest of MEA Sexually Transmitted Disease Testing Market Share, By Device, By Value, 2019–2029
List of Tables
Table 1 Global Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 2 Global Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 3 Global Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 4 Global Sexually Transmitted Disease Testing Market Size, By Region, By Value, 2019–2029
Table 5 North America Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 6 North America Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 7 North America Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 8 North America Sexually Transmitted Disease Testing Market Size, By Country, By Value, 2019–2029
Table 9 US Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 10 US Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 11 US Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 12 Canada Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 13 Canada Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 14 Canada Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 15 Europe Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 16 Europe Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 17 Europe Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 18 Europe Sexually Transmitted Disease Testing Market Size, By Country, By Value, 2019–2029
Table 19 Germany Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 20 Germany Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 21 Germany Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 22 UK Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 23 UK Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 24 UK Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 25 Italy Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 26 Italy Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 27 Italy Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 28 France Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 29 France Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 30 France Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 31 Spain Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 32 Spain Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 33 Spain Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 34 The Netherlands Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 35 The Netherlands Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 36 The Netherlands Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 37 Rest of Europe Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 38 Rest of Europe Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 39 Rest of Europe Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 40 Asia-Pacific Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 41 Asia-Pacific Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 42 Asia-Pacific Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 43 Asia-Pacific Sexually Transmitted Disease Testing Market Size, By Country, By Value, 2019–2029
Table 44 China Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 45 China Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 46 China Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 47 India Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 48 India Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 49 India Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 50 Japan Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 51 Japan Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 52 Japan Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 53 South Korea Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 54 South Korea Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 55 South Korea Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 56 Australia & New Zealand Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 57 Australia & New Zealand Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 58 Australia & New Zealand Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 59 Indonesia Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 60 Indonesia Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 61 Indonesia Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 62 Malaysia Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 63 Malaysia Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 64 Malaysia Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 65 Singapore Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 66 Singapore Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 67 Singapore Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 68 Philippines Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 69 Philippines Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 70 Philippines Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 71 Vietnam Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 72 Vietnam Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 73 Vietnam Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 74 Rest of APAC Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 75 Rest of APAC Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 76 Rest of APAC Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 77 Latin America Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 78 Latin America Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 79 Latin America Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 80 Latin America Sexually Transmitted Disease Testing Market Size, By Country, By Value, 2019–2029
Table 81 Brazil Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 82 Brazil Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 83 Brazil Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 84 Mexico Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 85 Mexico Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 86 Mexico Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 87 Argentina Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 88 Argentina Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 89 Argentina Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 90 Peru Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 91 Peru Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 92 Peru Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 93 Colombia Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 94 Colombia Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 95 Colombia Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 96 Rest of LATAM Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 97 Rest of LATAM Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 98 Rest of LATAM Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 99 Middle East & Africa Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 100 Middle East & Africa Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 101 Middle East & Africa Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 102 Middle East & Africa Sexually Transmitted Disease Testing Market Size, By Country, By Value, 2019–2029
Table 103 Saudi Arabia Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 104 Saudi Arabia Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 105 Saudi Arabia Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 106 UAE Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 107 UAE Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 108 UAE Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 109 Qatar Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 110 Qatar Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 111 Qatar Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 112 Kuwait Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 113 Kuwait Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 114 Kuwait Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 115 South Africa Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 116 South Africa Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 117 South Africa Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 118 Nigeria Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 119 Nigeria Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 120 Nigeria Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 121 Algeria Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 122 Algeria Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 123 Algeria Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 124 Rest of MEA Sexually Transmitted Disease Testing Market Size, By Disease, By Value, 2019–2029
Table 125 Rest of MEA Sexually Transmitted Disease Testing Market Size, By Location, By Value, 2019–2029
Table 126 Rest of MEA Sexually Transmitted Disease Testing Market Size, By Device, By Value, 2019–2029
Table 127 Abbott Laboratories Company Overview
Table 128 Abbott Laboratories Financial Overview
Table 129 BioMérieux, Inc. Company Overview
Table 130 BioMérieux, Inc. Financial Overview
Table 131 Becton Dickinson Company Overview
Table 132 Becton Dickinson Company Financial Overview
Table 133 Danaher Corporation Company Overview
Table 134 Danaher Corporation Financial Overview
Table 135 Bio-Rad Laboratories, Inc. Company Overview
Table 136 Bio-Rad Laboratories, Inc. Financial Overview
Table 137 Hologic, Inc. Company Overview
Table 138 Hologic, Inc. Financial Overview
Table 139 Diasorin Molecular LLC Company Overview
Table 140 Diasorin Molecular LLC Financial Overview
Table 141 Roche Holding AG Company Overview
Table 142 Roche Holding AG Financial Overview
Table 143 Orasure Technologies, Inc. Company Overview
Table 144 Orasure Technologies, Inc. Financial Overview
Table 145 Thermo Fisher Scientific Inc. Company Overview
Table 146 Thermo Fisher Scientific Inc. Financial Overview
Table 147 AccuBioTech Co. Ltd. Company Overview
Table 148 AccuBioTech Co. Ltd. Financial Overview
Table 149 AdvaCare Pharma Company Overview
Table 150 AdvaCare Pharma Financial Overview
Table 151 BIOGENIX Inc. Pvt. Ltd. Company Overview
Table 152 BIOGENIX Inc. Pvt. Ltd. Financial Overview
Table 153 CTK Biotech Inc. Company Overview
Table 154 CTK Biotech Inc. Financial Overview
Table 155 Everlywell Inc. Company Overview
Table 156 Everlywell Inc. Financial Overview
Table 157 F. Hoffmann La Roche Ltd. Company Overview
Table 158 F. Hoffmann La Roche Ltd. Financial Overview
Table 159 Gilead Sciences Inc. Company Overview
Table 160 Gilead Sciences Inc. Financial Overview
Table 161 GlaxoSmithKline Plc Company Overview
Table 162 GlaxoSmithKline Plc Financial Overview
Table 163 Merck and Co. Inc. Company Overview
Table 164 Merck and Co. Inc. Financial Overview
Market Segmentation
By Disease
-
Chlamydia
-
Syphilis
-
Gonorrhoea
-
Hyper Simplex Virus
-
Human Immunodeficiency Virus
-
Chancroid
By Location
-
Laboratory
-
Point of Care (POC)
By Device
-
Laboratory Devices
-
Point of Care (PoC) Devices
By Region
-
North America
-
Europe
-
Asia Pacific (APAC)
-
Latin America
-
Middle East and Africa (MEA)
To request a free sample copy of this report, please complete the form below.
We value your investment and offer free customization with every report to fulfil your exact research needs.
Frequently Asked Questions (FAQs):
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research Support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Custom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.